Key result
A 3-month lifestyle intervention in overweight Japanese men significantly decreased serum Angptl2 levels from 3.02 ng/ml at baseline to 2.79 ng/ml at 3 months (p=0.001).
Why the study?
Does a 3-month lifestyle intervention reduce serum Angptl2 levels in overweight Japanese men?
Cohort (n=154)
No
Does a 3-month lifestyle intervention reduce serum Angptl2 levels in overweight Japanese men?
Absolute Event Rate: 2.79% vs 3.02%
p-value: p=0.001
A 3-month lifestyle intervention in overweight men significantly reduces serum Angptl2 levels, which correlates with reductions in adiposity and improvements in lipid metabolism.
May lower Angptl2 via lifestyle intervention in overweight men; leaves open effects on clinical outcomes.
OBJECTIVE: Overexpression of Angiopoietin-like protein 2 (Angptl2) in obese adipose tissues promotes adipose tissue inflammation and its-related metabolic abnormalities. In a comparative study with adiponectin, we investigated whether alterations in serum Angptl2 concentrations reflect the effect of lifestyle intervention on weight loss and improved metabolic parameters in overweight subjects. METHODS: A total of 154 Japanese men (age, 40.9±5.1 years; body mass index, 26.9±3.6 kg m(-2); abdominal circumference, 94.1±8.9 cm) underwent a 3-month lifestyle intervention and underwent follow-up for 3 months thereafter. RESULTS: Decreased serum Angptl2 levels, but not increased serum adiponectin levels, were immediately apparent at the end of 3-month lifestyle intervention. Angptl2 levels continued to decrease for 3 months in parallel with body weight loss and improvement in metabolic indicators. In subjects showing 6% weight reduction, markedly reduced Angptl2 levels were detected at the end of 3-month intervention, whereas increased adiponectin levels were detected 3 months after the end of intervention. Multivariate analysis revealed changes in serum Angptl2 levels associated with changes in triglycerides (TGs), aspartate aminotransferase and alanine aminotransferase. In contrast, changes in serum adiponectin levels were associated with altered high-density lipoprotein cholesterol (HDL-C) and fasting plasma glucose levels. CONCLUSION: A 3-month lifestyle intervention promoted weight reduction and improved glucose and lipid metabolism, an effect maintained 3 months later. Notably, our findings indicate that decreased Angptl2 levels are a good indicator of reduced visceral fat and metabolic improvement at early stages of lifestyle intervention. Thus, Angptl2 reflects adiposity and might be a key protein to regulate inflammation and TG metabolism, whereas adiponectin levels could reflect improved glucose and HDL-C metabolism.
No takes yet. Share an insight, caveat, or question.
Muramoto et al. (2011) conducted a cohort in Overweight (n=154). Lifestyle intervention vs. Baseline was evaluated on Serum Angptl2 levels at 3 months (p=0.001). A 3-month lifestyle intervention in overweight Japanese men significantly decreased serum Angptl2 levels from 3.02 ng/ml at baseline to 2.79 ng/ml at 3 months (p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: